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LETTERS
Bordetella 
pertussis Isolates,
Finland 
To the Editor: Pertussis, or
whooping cough, is a highly conta-
gious respiratory disease in humans
caused by Bordetella pertussis.
Reemergence of pertussis has been
observed in many countries with high
vaccination coverage. In the United
States, reported cases of pertussis in
adolescents and adults have increased
since the 1980s, despite increasingly
high rates of vaccination in infants
and children (1). At the same time,
clinical  B. pertussis isolates have
become antigenically divergent from
vaccine strains (2,3). This observation
has raised the question of whether
vaccination has caused selection for
the variant strains, and whether the
reemergence of pertussis in vaccinat-
ed populations is due to vaccination
not protecting against these antigenic
variants as effectively as it protects
against vaccine type strains. On the
other hand, vaccine-induced immuni-
ty wanes over time, and pertussis is
not only a childhood disease but also
a frequent cause of prolonged illness
in adults and adolescents today (4). 
In Finland, children are vaccinated
with diphtheria-tetanus whole-cell
pertussis vaccine at 3, 4, and 5 months,
and from 20 to 24 months of age. The
whole-cell vaccine contains 2 strains
and has remained unchanged since
1976. The vaccine strain 18530 con-
tains fimbriae 3 (Fim3), pertussis
toxin S1 subunit D (PtxS1D), and per-
tactin 1(Prn1); the other vaccine
strain, 1772, contains Fim2,3, PtxS1B,
and Prn1. Ninety-six percent of
Finland’s population has been vacci-
nated with 4 doses of pertussis. The
incidence of pertussis is highest in
infants <1 year of age and in school-
children from 6 to 14 years old,
although about 30% of the cases occur
in adults older than 20 years. In
Finland, as in many other countries
with large-scale vaccination programs,
several outbreaks of pertussis occurred
in the 1990s. We studied prospectively
3 pertussis outbreaks in 2 elementary
schools and 1 municipality in south-
western Finland (5,6). The aim of the
study was to characterize the strains
circulating and causing outbreaks and
to track the transmission of B. pertus-
sis during these outbreaks.
Sample were collected and primary
cultures were done as described earli-
er (5,6). (See online Tables 1–3 at
http://www.cdc.gov/ncidod/EID/
vol11no01/04-0632.htm#table1,
http://www.cdc.gov/ncidod/EID/
vol11no01/04-0632.htm#table2,
http://www.cdc.gov/ncidod/EID/
vol11no01/04-0632.htm#table3) The
outbreaks took place in 3 rural munic-
ipalities: in 1992, in Paimio with
1,400 inhabitants; in 1995, in Oripää
with 3,500 inhabitants; and in 1996, in
Rusko with 9,900 inhabitants. The
isolates were obtained from schools
and local health centers. In addition, 1
isolate was obtained from a household
contact (See online Table 3 at
http://www.cdc.gov/ncidod/EID/
vol11no01/04-0632.htm#table3).
Most of the cases occurred in school-
children >8 years of age and in adults.
Various DNA fingerprinting tech-
niques, such as IS1002-based restric-
tion fragment length polymorphism
(IS1002-RFLP) and pulsed-field gel
electrophoresis (PFGE) have been
used to study B. pertussis isolates
(7–10). DNA polymorphism analysis
of prn and ptxS1 has previously been
used as a typing method for detecting
antigenic shifts (2,3,8). In addition to
prn and ptxS1, only tracheal coloniza-
tion factor (tcfA), a surface–associated
protein involved in the adhesion of B.
pertussis to host cells, has been found
to be polymorphic in recent B. pertus-
sis isolates (3). The isolates were
typed as described earlier (8,10). 
Of the 46 isolates, 43 (94%)
expressed Fim2, 2 (4%) expressed
both Fim2 and Fim3, and 1 (2%)
expressed Fim3 (See online Tables).
The predominant prn allele in all 3
outbreaks was prn2, contained by 39
(85%) of the isolates. Six (13%) iso-
lates contained prn3 and 1 (2%) iso-
late contained prn4. All isolates con-
tained the ptxS1Aallele. The predom-
inant tcfA allele was tcfA2, contained
by 42 (91%) of the isolates. Four (9%)
isolates contained tcfA3. The tcfA3
allele was observed only in isolates
with prn3. All but 1 of the 27 isolates
subjected to the IS1002-RFLP analy-
sis had the same pattern.
Seven PFGE patterns were found
among the 46 isolates studied. The
isolates were considered to be closely
related, as the differences between the
patterns were small, differing by 1 or
2 bands. Three PFGE patterns were
found in both Paimio and Rusko. A
major pattern was circulating in each
of the schools A, B, and C, which
indicates that pertussis is effectively
transmitted in schools. However, in
school D, the isolate from the index
patient had PFGE pattern 5, whereas
the rest of the isolates from patients in
school D had pattern 6. In addition,
the 1 isolate obtained from a house-
hold contact had a distinct PFGE pat-
tern, 7. Similarly, in Paimio, the iso-
late from the index patient had a dis-
tinct PFGE pattern, 1. These findings,
as well as the fact that 3 PFGE pat-
terns were found in both Paimio and
Rusko, indicate that several B. pertus-
sis strains may have been circulating
simultaneously in these small com-
munities. 
Our results suggest that ptxS1 is
not a useful marker in outbreaks to
detect antigenic shifts. IS1002-RFLP
was less discriminative than XbaI
PFGE, which agree with results of
previous studies (8). Most cases
occurred in schoolchildren and adults,
confirming epidemiologic findings
from other countries with vaccination
programs. Our results support the ear-
lier observation that the recent B. per-
tussis isolates are antigenically differ-
ent from vaccine strains. Several B.
pertussis strains could circulate
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simultaneously even in small commu-
nities, and only some strains, possibly
with increased fitness, are capable of
spreading effectively. 
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Correction Vol. 10, No. 12
In the article entitled "Wildlife as Source of
Zoonotic Infections" by Hilde Kruse et al., errors
occurred in the 2nd paragraph under Factors
Influencing the Epidemiology of Zoonoses with a
Wildlife Reservoir on page 2068. The first sen-
tence incorrectly identified deer as a main reser-
voir for Borrelia burgdorferi. The corrected sen-
tence appears below:
The spirochete Borrelia burgdorferi, which causes
Lyme borreliosis, has its main reservoir among small
rodents and uses various Ixodes species as vectors
(13). 
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